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Vein graft surveillance: Is graft revision
without angiography justified and what
criteria should be used?
Mirza M. Idu, MD, Jacob Buth, MD, PhD, Wim C. J. Hop, MSc, PhD,
Philippe Cuypers, MD, Eric D. W. M. van de Pavoordt, MD, PhD, and Jan
M. H. Tordoir, MD, PhD, Rotterdam, The Netherlands
Purpose: The objective of this study was to assess the accuracy of color-flow duplex sur-
veillance parameters to detect infrainguinal vein graft stenoses and to investigate
whether graft revision without angiography is justified.
Methods: In a prospective study in which three centers participated, the data of graft sur-
veillance in 300 patients were analyzed. For the evaluation of surveillance criteria all
patients underwent a digital subtraction angiography if a graft stenosis was suspected.
To create a control group, in patients with normal grafts a consented digital subtraction
angiography was performed also. From these data the accuracy of seven duplex and three
ankle blood pressure-derived variables was assessed. The relation between various sur-
veillance criteria and continued graft patency was determined with life table analysis
with the transient state method.
Results: The mean follow-up period was 20 months (range, 1 to 40 months). At uni-
variate and multivariate analysis the peak systolic velocity (PSV) ratio provided the best
correlation with angiographic stenoses ‡ 70% (PSV ratio cutoff 3.0: sensitivity 80%,
specificity 84%). This finding did not differ between the participating centers. With life
table methods it was demonstrated that the best combination of efficacy (limitation of
the number of unnecessary revisions), safety (minimal number of correctable lesions
missed), and reduction of angiograms was obtained by a two-parameter surveillance
algorithm. This algorithm included a PSV ratio <2.5 to delineate patients in whom a
conservative approach without angiography or revision was appropriate, a PSV ratio
‡ 4.0 to indicate patients in whom vein graft revision without angiography could be
scheduled, and a group with PSV ratios between 2.5 and 4.0 in whom angiography was
to be performed to determine clinical management on the basis of the stenosis severity.
This algorithm had a positive predictive value of 93% and a negative predictive value of
89%. In addition, it resulted in a reduction of the number of angiograms of 49% com-
pared with a policy of angiographies in all patients with a PSV ratio ‡ 2.5.
Conclusions: The best criterion to identify a failing graft is the PSV ratio. With a two-
parameter algorithm for vein graft surveillance, the incidence of unnecessary revisions
and of missed high-grade lesions was acceptably low, whereas the number of angiograms
was reduced by one half. (J Vasc Surg 1998;27:399-413.)
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Autogenous vein grafts provide the best conduit
for bypass management of femoropopliteal and
femorocrural occlusive disease. However, bypass
longevity is threatened by the development of steno-
sis either from intimal hyperplasia or from fibrous
stricture development in 20% to 30%.1-3 Frequent
noninvasive examinations followed by elective revi-
sion of failing but nonoccluded grafts has become a
valued strategy that is believed to salvage conduits
and limbs.4-7
Angiography allows the demonstration of signif-
icant vein graft stenoses, and in fact this method was
used in the first comprehensive study reporting on
the phenomenon of graft stenosis by Szilagyi et al.1
in 1973. The presence of a significant angiographic
stenosis is a reliable predictor of graft failure unless
the lesion is repaired.8-10 There is no consensus
about which of the noninvasive methods or parame-
ters as applied during follow-up has the best correla-
tion with angiographically critical graft stenoses, nor
is there agreement on what outcomes of surveillance
measurements are reliable indicators of expected
graft failure or obvious need for intervention.
Replacing angiographic evaluation of vein graft
stenosis by duplex scanning would be advantageous.11
Graft occlusions may occur within the interval
between the surveillance visit and the confirmative
angiography.9 Avoiding arteriograms during follow-up
would not only result in less delay of the revisional pro-
cedure, it also would reduce the overall cost of graft
surveillance programs. This approach assumes that sur-
veillance examinations have a high positive predictive
value (PPV) and negative predictive value (NPV) to
avoid unnecessary interventions and to avoid missing a
large proportion of patients with failing grafts.
In this report the results are presented of a
prospective cohort study with strictly standardized
surveillance techniques, digital subtraction angiog-
raphy (DSA) in a series of patients with infrainguinal
venous bypasses, and a fixed protocol with regard to
interventions for documented severe lesions in the
graft or the adjacent arterial segments. The objec-
tives of this study were (1) to assess the accuracy of
different surveillance parameters in comparison with
angiography as a gold standard and (2) to examine
correlations of parameters with the fate of the graft
during follow-up. For the first analysis a comparison
is made on the basis of DSA performed in this series,
whereas in the second analysis the patients entering
the follow-up period constitute the statistical unit.
In addition, the threshold level for the angiographic
degree of stenosis to distinguish grafts with a high
and a low risk of failure was validated.
PATIENTS AND METHODS
Patients of three institutions following the same
surveillance protocol were included in a prospective
cohort surveillance study. Three hundred patients
with autologous vein bypass grafts of the infrain-
guinal arteries were studied. Patients entered the
study if they had undergone open bypass grafting
before discharge from the hospital. Only one graft
per patient was included in this study. The three par-
ticipating institutions were Catharina Hospital,
Eindhoven (177 grafts), Sint Antonius Hospital,
Nieuwegein (62 grafts), and University Hospital,
Maastricht (61 grafts). Forty-six patients with vein
grafts who underwent surgery in the same period
were not considered for analysis because of death of
the patient (11), irreversible graft occlusion (17),
amputation with open bypass within 30 days after
the operation (8), or no return for surveillance visits
(10). The operations were performed between June
1993 and September 1995, and the follow-up of this
study ended in September 1996. Of the 300 patients
179 (60%) were men, and 121 (40%) were women
(Table I). The mean age was 70 years (range, 33 to
93 years). Diabetes mellitus (type 1 or 2) was pre-
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Table I. Risk factors and graft characteristics in
300 infrainguinal vein grafts
Variables No. of grafts (%)
Presenting symptoms
Tissue loss from G or U 109 (36)
Rest pain 107 (36)
Claudication 78 (26)
Aneurysm 6 (2)
Associated disease and risk factors 
Female sex 121 (40)
Diabetes mellitus 117 (39)
Hypertension 94 (31)
History of smoking 210 (70)
History of other vascular disease 152 (51)
Preoperative data ABI
ABI <0.60 223 (78)*
SVS/ISCVS runoff score >2.0 178 (59)
Graft
Previous ipsilateral infrainguinal 83 (28)
reconstruction
Other than in situ graft 172 (57)
Proximal anastomosis below common 111 (37)
femoral artery
Proximal anastomosis below superficial 30 (12)
femoral artery
Crural distal anastomosis 150 (50)
Venovenous anastomosis 54 (18)
Minimal graft diameter <3.5 mm 38 (13)
G, gangrene; U, ulceration; SVS/ISCVS, Society for Vascular
Surgery/International Society for Cardiovascular Surgery.
*Incompressible vessels in 15 patients.
sent in 117 (39%) patients. Critical ischemia was the
indication for the bypass procedure in 216 (72%). A
total of 83 (28%) procedures were redo operations,
that is, new grafts, because a previous attempt of
revascularization of the popliteal or crural arteries in
the same limb had been performed. The distal anas-
tomosis was at the level of the popliteal artery or
tibioperoneal trunk in 150 (50%) and at a crural
artery in 150 (50%). The runoff score as determined
on the basis of preoperative angiograms12 indicated
an impaired runoff (score >2.0) in 178 (59%) of the
patients.
A variety of techniques were used to perform the
bypass procedures. In situ saphenous vein grafts
were used when the ipsilateral saphenous vein was
available and suitable for use. Ectopic veins were
either reversed or nonreversed, depending on the
vein taper and the optimal size match between vein
grafts and inflow and recipient arteries. Small distal
or fibrotic segments were replaced by a segment of
arm vein or greater saphenous vein. The procedures
were performed by staff surgeons in the three insti-
tutions or by vascular fellows assisted by the sur-
geon. Postoperative anticoagulation with coumarin
(Dicoumarol or Acenocoumarin) was instituted after
surgery in all patients without contraindications for
its use.
In the three participating institutions the same
graft surveillance protocol was used. The adherence
to the protocol was accomplished by frequent visits
of a data manager and a study nurse, who performed
the data collection. Vascular laboratory meetings
were organized regularly to ascertain a uniform
duplex scanning and measurement technique and
for recording of parameters. The surveillance exam-
inations were performed by a group of nine vascular
laboratory technicians.
Surveillance protocol. Before discharge from
the hospital graft patency was confirmed by a graft
velocity measurement at the mid-thigh level of the
bypass. For the study, however, only the outcomes
of entire bypass duplex scannings during follow-up
were used in addition with ankle pressure measure-
ments at rest and during reactive hyperemia (RH).
Surveillance visits were routinely performed at 6
weeks, 3 months, 6 months, 9 months, and 12
months. In grafts without abnormalities subsequent
follow-up examinations consisted of ankle blood
pressure measurements at rest and during RH at 18,
24, and 30 months after the operation. The rationale
for restricting duplex examinations to the first post-
operative year has been well documented in the lit-
erature.4
An intraarterial DSA (Catharina Hospital and
Sint Antonius Hospital) or an intravenous DSA
(University Hospital Maastricht) was performed if
one of the following criteria for a failing graft were
present: recurrent claudication or rest pain, interval
decrease of the ankle/brachial blood pressure index
(ABI) >0.15, a peak systolic velocity ratio (PSV
ratio) >2.0, a peak systolic velocity at the mid-thigh
section (for a length of at least 7 cm) of the graft
(PSV graft) <45 cm/sec, and an end-diastolic veloc-
ity >20 cm/sec. If the intravenous study had insuffi-
cient resolution, a subsequent intraarterial DSA was
performed. Accurate assessment of the angiographic
diameter ratio of stenotic and normal graft sites was
facilitated by multiple projections and by magnified
views. If at DSA examination a stenosis of 70% diam-
eter reduction (DR) or greater was observed either
in the graft, the anastomoses, or the adjacent artery
segments, a revisional procedure, either a percuta-
neous transluminal angioplasty or an open surgical
procedure, was planned. In fact, this angiographic
criterium was the sole determinant for the decision
for intervention. After the lesion was repaired, sur-
veillance was continued until 1 year after the revi-
sion. In case of a stenosis with a DR of 50% to 70%,
no intervention was undertaken, but subsequent
surveillance duplex examinations were performed at
reduced intervals. If no further increase of the PSV
ratio occurred, a conservative approach was adopt-
ed, and the surveillance schedule resumed at routine
intervals. Bypasses with less than 50% DR were con-
sidered normal grafts.
Patients without evidence of graft stenosis at sur-
veillance examination underwent a DSA after their
consent was obtained. These control DSA studies
were made either 6 months or 1 year after the opera-
tion, a choice that was determined by randomization.
Surveillance examination. Systolic ankle blood
pressure (ABP) measurements were performed with
the patient lying supine with a 15-cm wide blood
pressure cuff, and the average of two measurements
was recorded. The highest of the right and left sys-
tolic brachial blood pressure was used to determine
the ABI. ABP during reactive hyperemia was mea-
sured after suprasystolic thigh cuff inflation during a
3-minute period.
The color-flow duplex equipment that was used
consisted of an Acuson 128 XP/10 in the Catharina
Hospital, a Hewlett Packard Sonos 1000 in the
University Hospital Maastricht, and a Hewlett
Packard Sonos 2000 in the Sint Antonius Hospital.
In the three centers a 7.5 MHz transducer was
applied, unless the vein graft was deep, in which case
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a 5.0 MHz transducer was used. The examination
technique such as the use of similar angles of
insonation of the pulsed Doppler with respect to the
vessel axis, sites of velocity measurements, ankle
pressure measurements, and reactive hyperemia
induction was uniform in the participating vascular
laboratories. The vein graft was examined from the
groin down the entire length to below the distal
anastomosis on to the first centimeters of the recipi-
ent runoff artery. Color-coded images were studied
for stenotic flow patterns, and a percent DR was
measured by use of color image at the stenosis and
at a nearby normal graft segment. After an image of
the graft was obtained, midstream pulsed Doppler
velocity spectral signals were recorded from diseased
and normal vessel segments. The following parame-
ters were evaluated: (1) the peak systolic velocity at
a normal mid-thigh graft segment (PSV graft, cen-
timeters/second), (2) the PSV at the most severe
stenotic site (PSV-max, centimeters/second), (3)
the ratio of the PSV-max and the PSV at a nearby
normal segment, proximally (or distally in case the
graft stenosis was near the proximal anastomosis) of
the stenosis (PSV ratio), (4) the end-diastolic veloc-
ity at the site of the stenosis or in normal grafts at
the narrowest segment of the bypass below the knee
(centimeters/second), (5) diameter reduction of the
stenosis on the color image (DR%), (6) the duplex
measured flow in resting conditions at the mid-thigh
graft (flow-rest, milliliters/minute), (7) flow at the
mid-thigh graft during reactive hyperemia (flow
RH, milliliters/minute), (8) ABP at rest (millimeters
of mercury), (9) ABI, and (10) ABI at RH.
Study end points, data analysis. All data were
prospectively recorded and entered into a computer-
ized database. The 10 surveillance parameters were
correlated in a univariate analysis with angiographic
outcomes. In this part the study is based on the DSAs
performed in the corresponding time interval. The
criterion of an angiographic DR of 70% was selected
because in previous studies this degree of lesion has
been associated with a high risk of graft failure.8-10,13
Angiograms were dichotomized into groups with a
DR of 0% to 70% and a DR ‡ 70%. A univariate com-
parison of both outcomes was performed with the
use of the Mann-Whitney test. All noninvasive factors
that demonstrated a significant difference (p < 0.05)
for the angiographic categories in the univariate com-
parison were subjected to a multivariate analysis with
logistic regression models.14 Variables with an inde-
pendent correlation with the angiographic severity of
stenoses were identified by backward elimination of
the factors that contributed the least to the model.
Cumulative primary and secondary patency rates as
defined by the Ad Hoc Committee on Reporting
standards were determined by life table methods.12
Receiver operating characteristic curves were used to
determine threshold values that provided the best
separation in lesion categories.15
The occurrence of primary events in relation with
the presence of a time-dependent risk factor such as a
PSV ratio greater than a predefined level can be deter-
mined by a Cumulative Hazard Analysis and Transient
State Method with Kaplan-Meier curves.16,17 With
this method the cumulative primary patency rate is
assessed in two groups of observations. Group A
involves all patients as long as a surveillance measure-
ment remains within specified limits, for example a
PSV ratio <3.0 ( Fig. 1) . In this group the observation
time starts at the time of the procedure (T = 0). If the
PSV ratio exceeds 3.0, a patient ceases to be part of
group A and is further represented in group B.
Patients are part of group B from the moment their
surveillance parameters have exceeded the threshold
value (T = 0). In both groups any patient reaching an
end point of primary patency (primary event, i.e., a
graft revision or occlusion) is represented as a drop in
patency. Basically, this method, which was described by
Mantel and Byar16 in 1974, allows a comparison of
patency rates between patients with and without a
time-dependent risk factor.18 A perfect predictive value
of a risk factor regarding the occurrence of events is
represented by a 100% patency in group A and a zero
patency in group B.
RESULTS
Angiograms, graft revisions, and patencies.
In the 300 patients 351 DSA studies were per-
formed during follow-up. A total of 182 DSA stud-
ies were performed for a change in surveillance para-
meters, most commonly a PSV ratio >2.0, whereas
169 normal control DSA studies were performed in
vein grafts without focal increase of PSV. Excluded
from the study were 22 angiograms: 8 patients had
an angiogram but failed to appear for noninvasive
examinations, 5 patients had a graft occlusion with-
out identified stenosis, and 9 patients had a com-
plete occlusion of the runoff artery immediately dis-
tal of their bypass. All graft or runoff occlusions were
accurately diagnosed by color imaging and absence
of flow signals allowing determination of clinical
management. For correlation of angiographic find-
ings and listed surveillance parameters, 329 DSA
studies were available. 
The median follow-up period was 20 months
(range, 1 to 40 months). Localization of revised
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stenoses, types of revision, and numbers of graft
occlusions are summarized in Table II. Interventions
were performed in 84 (28%) of the grafts, and the
total number of revisions including multiple stenoses
and recurrences was 144. Primary graft occlusions
were diagnosed in 31 cases. In 16 patients the occlu-
sion occurred without obvious cause, but in 15 the
presence of a high-grade lesion was known. In the
latter cases there usually was a delay to revise the
graft and sometimes refusal or inability of the patient
to return for the procedure. The 2-year primary
patency determined by standard Kaplan-Meier life
table analysis was 58% (SE 3%), and the secondary
patency was 84% (SE 2%) for the total study group
(Appendix A, see also footnotes to Table II).
Seventy percent angiographic diameter reduc-
tion as a risk factor of occlusion. A validation was
performed whether graft stenoses of 70% angio-
graphic diameter reduction or greater imposed the
greatest risk for occlusion. Therefore the secondary
patency rate was compared for grafts with different
degrees of stenosis with the Transient State Method.
In this analysis the onset of the observation periods
coincided with the time of the arteriogram deter-
mining the classification. The 18-month secondary
patency rate in patients with <50% DR angiographic
stenoses was 99%, in stenoses of 50% to 70% DR the
patency was 87%, and in stenoses ‡ 70% it was 78% (p
< 0.05 for the latter category compared with the two
other categories, Appendix B). It should be noted
that as per protocol patients with a degree of steno-
sis less than 70% were not revised in this study,
whereas all patients with a 70% lesion or greater had
a graft revision planned. The validity of a 70% DR
threshold value as a discriminator between grafts
with a high risk of failure or otherwise was clearly
supported by this observation.
Graft surveillance parameters. All duplex- and
ABP-derived parameters were correlated for groups
with DSA-confirmed lesions <70% and ‡ 70% DR
(Table III). Differences were observed for all para-
meters except for graft flow-RH, and the significance
was borderline for the resting graft flow. Despite sta-
tistical differences a considerable overlap of parame-
ter outcomes occurred in the DSA study groups. The
best discrimination between grafts with and without
significant stenoses was observed in PSV-max and
PSV ratio, which are by definition strongly related to
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Fig. 1. Primary patency rates represented by Kaplan-Meier curves of patients with PSV ratio
<3.0 (group A) and patients with PSV ratio ‡ 3.0 (group B). In group A, T = 0 coincided with
time of operation, and in group B, T = 0 coincided with first time observed PSV ratio was ‡ 3.0.
Curve of group A depicts patency as long as PSV ratio has not exceeded 3.0 (Transient State
Method).
each other. No differences were seen in the correla-
tion of the PSV ratio and the angiographic degree of
stenosis among the three participating centers. Eight
variables that demonstrated a significant difference in
the univariate analysis were subjected to a multivari-
ate analysis by logistic regression. This resulted in a
model containing two variables (PSV ratio and ABP)
with an independent association with the presence of
a high-grade stenosis (Table IV).
As a next step receiver operating characteristic
curves were used to evaluate the sensitivity and
specificity of the PSV ratio alone and combined with
the ABP to identify graft stenoses ‡ 70% DR. Of PSV
ratio alone a value of 3.0 provided the best outcome
and was associated with a sensitivity of 80% and a
specificity of 84%. Use of the combined parameter
“PSV ratio and ABP” provided little improvement in
sensitivity and specificity compared with the PSV
ratio alone (Fig. 2). Therefore it was concluded that
to distinguish angiographic lesions of ‡ 70% from
grafts with less severe stenosis, use of the PSV ratio
only was sufficient. In an additional multivariate
analysis in graft subgroups, it was demonstrated that
of the eight surveillance parameters, the PSV ratio
had the best correlation with the presence of high-
grade lesions in in situ or ectopic nonreversed grafts,
in reversed grafts, in femoropopliteal grafts, and in
infrapopliteal grafts.
Graft patency relative to surveillance parame-
ters. During the total follow-up-period 103 (34%)
of 300 patients reached a primary patency end point
(84 revisions and 19 primary occlusions within 6
months of the last surveillance duplex examination).
Redo interventions were not included for this analy-
sis. (See the notes to Table II for a detailed account of
graft revisions and occlusions in life table analysis.)
From the investigation described previously it
appeared that the PSV ratio was the best indicator of
a high-grade graft stenosis. Therefore a series of cut-
off values of this parameter was correlated with the
occurrence of primary clinical events by Cumulative
Hazard Analysis with the Transient State Method
and Kaplan-Meier graphs. It is of note that in this
study the only indication for revision of a graft lesion
was a stenosis of 70% DR or greater at angiography.
The first assessment was for a PSV ratio of 3.0. Of the
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Table II. Graft stenoses, revisions, and occlusions
in 300 patients during follow-up
No.
Localization of revised stenoses (DSA) (n = 144 stenoses)*
Inflow artery 1
Proximal anastomosis 30
Graft above the knee 27
Graft at the knee 18
Graft below the knee 17
Distal anastomosis 39
Runoff artery 12
Type of first time revision (n = 84 revisions)†
PTA (atherectomy, stent) 35
Patchplasty 17
Interposition graft 14
Jump graft 18
Simultaneous revision of multiple stenoses (no. of revisions) 13
Subsequent revisions (no. of patients) 
2 revisions 31
3 revisions 8
Graft occlusions as primary event (n = 31 occlusions)†
Occlusion without obvious cause 16
Occlusion with known high grade stenosis 15
*The total number of 144 revised stenoses involved the first time
revisions (n = 84), simultaneous revisions of multiple stenoses (n
= 13), and subsequent second and third revisions (n = 47).
†The total of 31 occlusions together with 84 first-time revisions
constituted the patients with a primary event (n = 115) in the
regular life table primary graft patency analysis for 300 patients
(Appendix A). In 12 patients the occlusion was later than 6
months after the last surveillance examinations, rendering any
relation uncertain. Therefore these were not considered as a pri-
mary event in the Transient State life table, leaving 103 primary
event patients for analysis (Appendix B, C, and D).
Table III. Univariate correlation of duplex and
ankle blood pressure derived parameters and DSA
category with a DR <70% and a DR ‡ 70% stenosis 
DSA <70% DSA ‡ 70% Significance
mean (± SD) mean (± SD) two-tailed
PSV graft 60.1 (± 23.9) 46.9 (± 23.2) <0.001
PSV-max 147.4 (± 76.7) 270.0 (± 108.2) < 0.001
PSV ratio 1.92 (± 1.1) 5.44 (± 2.64) <0.001
EDV 6.3 (±16.3) 33.9 (± 48.5) <0.001
DR % 24.1 (± 22.7) 53.9 (± 19.2) <0.001
Flow rest 189.8 (± 203.3) 164.4 (± 170.1) 0.019
Flow RH 267.9 (± 285.4) 257.6 (± 294.6) 0.164
ABP 147.7 (± 39.8) 120.4 (± 38.4) <0.001
ABI 0.95 (± 0.253) 0.79 (± 0.26) <0.001
ABI RH 0.92 (± 0.249) 0.73 (± 0.28) <0.001
EDV, End-diastolic volume.
Table IV. Logistic regression model relating two
variables to the probability of stenosis with ‡ 70%
DR
Standard
Variable b error Wald test* p Value
10log (PSV ratio) 6.81 0.78 75.87 <0.0001
ABP (mm Hg) -0.014 0.004 9.86 0.002
Constant -1.61 0.74 - -
*Degrees of freedom = 1.
300 patients in the study population, 264 initially
had a PSV ratio <3.0 and therefore belonged to
group A, whereas 97 patients either had a PSV ratio
‡ 3.0 at their initial surveillance examination or at a
later time during follow-up to be part of group B
(Fig. 1, Appendix C). The 18-month primary paten-
cy rate of group A was 86%, and in group B it was
15%. Alternatively, these findings may be expressed as
NPV, represented by the primary patency in group A,
and PPV, which is equal to 100 minus the primary
patency in group B. Thus the 18-month NPV of a
PSV ratio 3.0 is 86%, and the PPV is 85%. This rep-
resents a just moderate agreement with the actual
clinical course. Primary events despite a PSV ratio
<3.0 occurred in 27 patients, and in 21 patients
events failed to appear, although they had a PSV ratio
‡ 3.0. For clinical application an algorithm based on a
single surveillance parameter does not appear suffi-
ciently accurate to replace prerevision angiography.
In 23 patients the PSV ratio progressed from
<2.5 to ‡ 4.0 during the surveillance period. The
PPV and NPV of PSV ratios 2.5, 3.0, and 4.0 are
represented together in Fig. 3. None of these crite-
ria was entirely correct in indicating whether a pri-
mary event would or would not occur, that is, the
PPV and NPV were less than 100% (Table V). A
PSV ratio of 2.5 was associated with an 18-month
patency rate of 89% in group A, whereas a PSV ratio
of 4.0 had a patency rate of 7% in group B. If the
best predictive values were combined with the use of
PSV ratios 2.5 and 4.0 in one algorithm, a better
correlation with the occurrence of primary events
was obtained than with one cutoff value of 3.0 (Figs.
3 and 4 and Appendix D). The accuracy of this cri-
terion was represented by an NPV of 89% and a PPV
of 93% (Table V). If used as an algorithm, the obser-
vation of a PSV ratio <2.5 may be interpreted as a
graft not at risk, and graft surveillance should be
continued. If a PSV ratio ‡ 4.0 is recorded, a graft is
at high risk for failure, and a revision should be
scheduled without the need of a pretreatment
angiogram. Cases with PSV ratios between 2.5 and
4.0 represent an intermediate risk group, and an
angiographic study is indicated to verify whether a
stenosis of 70% DR or greater is present.
In Table VI the consequences of the two-para-
meter algorithm are summarized. If this algorithm
had been applied, five patients with a PSV ratio ‡ 4.0
would have undergone an intervention but in fact
had no revision, because their angiographic stenoses
were less than 70% (false-positive observations). The
angiographic stenoses in these five patients had a DR
of 60%, 55%, 55%, 45%, and 40%. Had interventions
been performed on the basis of duplex findings,
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Fig. 2. Receiver operating characteristic curves of PSV ratio and of combined parameter PSV
ratio and ABP.
these may have been considered unnecessary treat-
ment. Twenty grafts had a primary event despite a
PSV ratio <2.5 (false-negative observation). This
category included a sudden graft occlusion without
obvious cause in 8 patients and revision of high-
grade lesions on the basis of arteriograms in 12
patients. These latter patients, although they had no
signs of a localized velocity increase, still had lesions
in the graft, the inflow, or the runoff. Angiograms
were requested because of a “low flow state” (PSV
graft <45 cm/sec) in seven of these patients and a
return of severe symptoms in four patients, and in
only one patient the stenosis was detected coinci-
dentally on a protocol-directed control DSA.
Moreover, in the two-parameter algorithm 64
DSAs were required in patients with a PSV ratio
between 2.5 and 4.0 (Table VI), whereas a graft
revision without angiography would have been
scheduled in 61 patients (true-positive diagnosis,
i.e., patients with a PSV ‡ 4.0 and terminal event,
Appendix D). This result implied a 49% reduction in
DSAs compared with a policy of requesting an
angiogram in any patient with a PSV ratio of 2.5 or
greater. On the basis of these observations it was
concluded that a two-parameter algorithm could be
practically applied in a surveillance program to limit
the use of angiographic studies.
DISCUSSION
It is generally accepted that the follow-up of
patients with infrainguinal vein grafts should be
directed toward the identification of failing grafts. At
this stage relatively minor procedures can often avert
impending graft failure.19,20 For the identification of
grafts with stenotic lesions ABP measurements and
more recently duplex and color-flow duplex exami-
nations have been used.4,21-24 With duplex examina-
tions low-velocity and high-velocity criteria can be
distinguished. The former criterion requires only
measurements of the PSV at a fixed point at mid-
graft level (PSV graft). It has been observed, howev-
er, that this criterion has a low sensitivity for focal
lesions and that low PSV graft values (low-flow state
grafts) are frequently caused by runoff or inflow dis-
ease.13,25,26 At present the most commonly used
color-flow duplex examination includes tracing of
the entire graft, identification of sites with flow dis-
turbance, and measurement of the PSV at the steno-
sis. Absolute PSV values and the ratio of the PSV at
the stenosis and a normal adjacent arterial segment
are used. Threshold values for the PSV ratio vary in
the literature from 1.5 to 3.5.4,10,23,25,27,28
In this study the correlation of a set of 10
duplex- and ABP-derived parameters, all reported in
the literature, were determined. In addition to the
parameters described previously, reactive hyperemia
tests combined with ABI- and duplex-derived vol-
ume flow measurements were included.29,30 End-
diastolic velocities were recorded as well. This vari-
able has been indicated as a correlant with high-
grade graft lesions, a relationship of which the
hemodynamic background was recently described
by Idu et al.9 and Papanicolaou et al.31 Correlation
of all parameters and the degree of stenosis as mea-
sured on the angiograms was performed. All angio-
graphic diameter reductions and surveillance vari-
ables were obtained in a strictly uniform fashion in
the three institutions that participated in this care-
fully monitored prospective study. The surveillance
parameters were determined by different duplex
apparatus by a group of nine vascular laboratory
technicians. Nevertheless, correlation of key surveil-
lance and angiographic variables resulted in compa-
rable outcomes in the institutions. With multivariate
analysis the PSV ratio and the ABP appeared to be
the most important independent predictors of a sig-
nificant stenosis, overtoning all other parameters.
The combination of these two variables, however,
provided hardly a better sensitivity and specificity to
identify graft stenosis ‡ 70% than the PSV ratio
alone. A PSV ratio >3.0 was a reasonable indicator
of the presence of a stenosis ‡ 70%, with a sensitivity
of 80% and a specificity of 84%. Therefore the PSV
ratio was used as the only variable for further analy-
sis.
Most vascular surgeons still consider intraarterial
DSA mandatory before performing an intervention
on a graft stenosis detected by noninvasive surveil-
lance methods. However, there is some variation in
the severity of the stenosis that is considered to rep-
resent a considerable risk of graft failure. A DR of
50% has been proposed as the critical level by sever-
al authors,4,23,25,32,33 whereas others believe a lesion
with a 70% DR indicates a failing vein graft.2,8-
10,13,27 It may be assumed that these differences at
least partly account for the variations in the critical
PSV ratios that have been reported in the literature.
In this study the angiographic DR was measured by
radiologists blinded for the findings at duplex exam-
inations. In a validating assessment we found that a
70% threshold correlated significantly with graft fail-
ure. Nonrevised stenoses of 50% to 70% had a bet-
ter patency than stenoses of 70% DR or greater,
which fell in the patient category with revisions. 
Angiography to confirm a suspected asympto-
matic graft lesion is cumbersome, and it causes delay
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of effective treatment, which may result in graft fail-
ure if the stenosis is high-grade. In this prospective
study 15 vein grafts with known presence of a steno-
sis failed during the interval between the last surveil-
lance visit and the intervention. In addition, angio-
graphic evaluation adds considerably to the cost of
follow-up, making surveillance programs less cost-
effective. A surveillance schedule by which angiogra-
phy is avoided altogether would be ideal.11 It was
examined whether a single-parameter surveillance
algorithm based on a PSV ratio of 3.0 provided such
a scheme. However, an NPV of 86% (27 patients
false-negative) and a PPV of 85% (21 patients false-
positive) was not satisfactory. To compare the posi-
tive and negative predictive values of different sur-
veillance parameters, an appropriate statistical tech-
nique was used.18 This statistic is very similar to the
log rank statistics, except that group membership is
not fixed along time. With Cumulative Hazard
Analysis and the Transient State Method using
Kaplan-Meier life tables, PSV ratios above a thresh-
old value were considered risk factors, and their
agreement with the actual occurrence of primary
events was assessed. In this analysis patients with nor-
mal PSV ratios served as a pseudocontrol group.
Although not all grafts with a high-grade steno-
sis occlude and some without lesions still fail, no sur-
veillance algorithm will be perfect. Requirements for
an algorithm in our view should include as a first pri-
ority the avoidance of unnecessary interventions,
which corresponds with a high PPV. The second pri-
ority is to miss as few severe stenoses as possible, cor-
responding with a high NPV. The final requirement
is to avoid angiography or at least a portion of it.
The two-parameter algorithm outlined in this study
distinguished three risk classes for graft failure
requiring different management strategies. The
algorithm implicated a conservative approach in
patients with a PSV ratio <2.5, a revision without
preceding angiography with PSV ratios >4.0, and a
DSA in patients with PSV ratios between 2.5 and
4.0. The noninvasive diagnostic criteria when corre-
lated with the actual angiographic findings had a
PPV of 93% and an NPV of 89%. Of the five patients
with a false-positive diagnosis, three had a stenosis
greater than 50% at the time of angiography, which
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Fig. 3. Primary patency rates represented by Kaplan-Meier curves of patients with PSV ratios
less (upper curves) or greater (lower curves) than 2.5, 3.0, and 4.0 (Transient State Method).
Table V. Prediction of end points of primary
patency by different PSV ratios
PSV ratio threshold value NPV (%) PPV (%)
2.5 89 79
3.0 86 85
4.0 80 93
Indicated NPV and PPV represent 18-month value.
perhaps might have justified a revision. Of the 20
patients with a false-negative diagnosis, 8 had a graft
occlusion without any previous duplex or angio-
graphic evidence of a stenotic lesion. We assume that
these grafts could not have been salvaged by a revi-
sion. Of the other patients, only one had a com-
pletely missed stenosis, whereas the other patients
had either “low-flow state” grafts or recurrent clini-
cal symptoms. Although these variables are poor
indicators of graft stenoses in statistical models, they
do have clinical significance and should be consid-
ered combined with high-velocity criteria.33,34 Thus
it could be argued that with a structured noninvasive
diagnostic protocol and a reduced use of angiogra-
phy in a series of 300 patients, only 2 with a false-
positive diagnosis and 1 with a false-negative diag-
nosis would have received inappropriate treatment,
which seems an acceptably low rate.
The two-parameter algorithm should be evaluat-
ed in a future prospective study. Other aspects than
the degree of stenosis that may influence planning of
interventions are length and multiplicity of lesions.
Both features can be studied adequately by modern
color-flow duplex equipment. Lesions of less than 1
cm can be scheduled for percutaneous angioplasty
and longer lesions for operative repair either by
patch angioplasty or by interposition grafting.35
In conclusion, of many surveillance parameters
the PSV ratio has the best correlation with the
angiographic degree of stenosis. An algorithm with
two cutoff levels to delineate patient groups with a
low, an intermediate, and a high risk of graft failure
seems applicable. Clinical management can be based
on this decision tree. The number of angiograms
during follow-up in patients with a significantly
increased PSV ratio can be reduced considerably,
because these must be requested in the intermediate
group only.
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Table VI. Unnecessary revisions, improper no-
treatments, and required angiograms with a two-
parameter surveillance algorithm
Consequences if No. of 
Diagnosis algorithm was applied patients
False-positive Unnecessary revisions 5
(PSV ratio ‡ 4.0) (of lesions with DR <70%)
False-negative Acute occlusion, or improper 20
(PSV ratio <2.5) no-treatment
(despite lesions with DR ‡ 70%)
Uncertain DSAs required 64
(PSV ratio 2.5 - 4.0)
Two-parameter algorithm includes conservative approach in PSV
ratios <2.5, DSA in PSV ratios 2.5 to 4.0 to determine the degree
of stenosis (as the basis to decide about graft revision) and
whether an intervention is indicated, and intervention without
angiogram in PSV ratios ‡ 4.0.
Fig. 4. Primary patency rates represented by Kaplan-Meier curves of patients with PSV ratio
<2.5 (group A) and patients with PSV-ratio ‡ 4.0 (group B) (Transient State Method).
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Appendix A. Life table primary and secondary graft patency analysis for 300 infrainguinal vein grafts
No. grafts No. grafts with No. grafts Interval Cumulative Standard 
Interval (mo) at risk terminal events withdrawn patency rate patency rate error
Primary patency
0-3 300 36 3 0.88 0.88 0.02
3-6 261 35 10 0.86 0.76 0.02
6-9 216 26 10 0.88 0.67 0.03
9-12 180 5 25 0.97 0.65 0.03
12-15 150 7 37 0.95 0.61 0.03
15-18 106 3 10 0.97 0.59 0.03
18-21 93 1 18 0.99 0.59 0.03
21-24 74 1 13 0.99 0.58 0.03
24-27 60 0 13 1.00 0.58 0.03
Secondary patency
0-3 300 2 5 0.99 0.99 0.01
3-6 293 16 11 0.94 0.94 0.01
6-9 266 6 12 0.98 0.92 0.02
9-12 248 2 36 0.99 0.91 0.02
12-15 210 3 44 0.99 0.89 0.02
15-18 163 2 17 1.00 0.88 0.02
18-21 144 0 24 0.99 0.87 0.02
21-24 120 1 22 0.99 0.86 0.02
24-27 97 1 25 0.97 0.84 0.02
Appendix B. Life table secondary graft patency analysis for 300 patients with infrainguinal vein grafts rela-
tive to the angiographic diameter reduction (Transient State Method)
No. grafts No. grafts with No. grafts Interval Cumulative Standard 
Interval (mo) at risk terminal events withdrawn patency rate patency rate error
Angiographic DR <50%
0-3 117 1 17 0.99 0.99 0.01
3-6 99 0 26 1.00 0.99 0.01
6-9 67 0 6 1.00 0.99 0.01
9-12 67 0 20 1.00 0.99 0.01
12-15 47 0 4 1.00 0.99 0.01
15-18 43 0 16 1.00 0.99 0.01
18-21 27 0 7 1.00 0.99 0.01
21-24 20 0 9 1.00 0.99 0.01
Angiographic DR 50% - 70%
0-3 36 1 3 0.97 0.97 0.03
3-6 32 1 4 0.97 0.94 0.04
6-9 27 0 4 1.00 0.94 0.04
9-12 23 0 6 1.00 0.94 0.04
12-15 17 0 0 1.00 0.94 0.04
15-18 17 1 5 0.93 0.87 0.07
18-21 11 0 3 1.00 0.87 0.07
21-24 8 0 3 1.00 0.87 0.07
Angiographic DR ‡ 70%
0-3 88 13 5 0.85 0.85 0.04
3-6 70 2 2 0.97 0.82 0.04
6-9 66 2 9 0.97 0.80 0.04
9-12 55 1 6 0.98 0.78 0.05
12-15 48 0 11 1.00 0.78 0.05
15-18 37 0 10 1.00 0.78 0.05
18-21 27 0 6 1.00 0.78 0.05
21-24 21 1 3 0.95 0.74 0.06
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Appendix C. Life table primary graft patency analysis for 300 patients with infrainguinal vein grafts rela-
tive to observed PSV ratio <3.0 or ‡ 3.0 (Transient State Method)
No. grafts No. grafts with No. grafts Interval Cumulative Standard 
Interval (mo) at risk terminal events withdrawn patency rate patency rate error
Group A: PSV <3.0
0-3 264 5 10 0.98 0.98 0.01
3-6 249 9 45 0.96 0.94 0.02
6-9 195 8 21 0.96 0.90 0.02
9-12 166 1 31 0.99 0.89 0.02
12-15 134 3 34 0.97 0.87 0.02
15-18 97 1 11 0.99 0.86 0.03
18-21 85 0 17 1.00 0.86 0.03
21-24 68 0 13 1.00 0.86 0.03
Group B: PSV ‡ 3.0
0-3 97 62 2 0.35 0.35 0.05
3-6 33 7 3 0.78 0.27 0.05
6-9 23 3 5 0.85 0.23 0.04
9-12 15 2 4 0.85 0.20 0.04
12-15 9 2 0 0.78 0.15 0.04
15-18 7 0 0 1.00 0.15 0.04
18-21 7 0 3 1.00 0.15 0.04
21-24 4 0 3 1.00 0.15 0.04
Appendix D. Life table primary graft patency analysis for 300 patients with infrainguinal vein grafts rela-
tive to observed PSV ratio (Transient State Method)
No. grafts No. grafts with No. grafts Interval Cumulative Standard 
Interval (mo) at risk terminal events withdrawn patency rate patency rate error
PSV ratio: 2.5
Group A (PSV ratio <2.5)
0-3 252 5 8 0.98 0.98 0.01
3-6 239 5 46 0.98 0.96 0.01
6-9 188 6 22 0.97 0.92 0.02
9-12 160 1 31 0.99 0.92 0.02
12-15 128 2 36 0.98 0.90 0.02
15-18 90 1 10 0.99 0.89 0.02
18-21 79 0 12 1.00 0.89 0.02
21-24 64 0 12 1.00 0.89 0.02
Group B (PSV ratio ‡ 2.5)
0-3 113 63 4 0.43 0.43 0.05
3-6 46 11 3 0.75 0.33 0.05
6-9 32 5 5 0.83 0.27 0.04
9-12 22 2 4 0.90 0.24 0.04
12-15 16 2 2 0.87 0.21 0.04
15-18 12 0 0 1.00 0.21 0.04
18-21 12 0 4 1.00 0.21 0.04
21-24 8 0 6 1.00 0.21 0.04
PSV ratio: 4.0
Group A (PSV ratio <4.0)
0-3 273 7 10 0.97 0.97 0.01
3-6 256 12 32 0.95 0.93 0.02
6-9 212 15 17 0.93 0.86 0.02
9-12 180 2 30 0.99 0.85 0.02
12-15 148 4 41 0.97 0.82 0.03
15-18 103 2 11 0.98 0.80 0.03
18-21 90 0 18 1.00 0.80 0.03
21-24 72 0 13 1.00 0.80 0.03
Group B (PSV ratio ‡ 4.0)
0-3 66 51 0 0.23 0.23 0.05
3-6 15 7 1 0.52 0.12 0.04
6-9 7 1 0 0.86 0.10 0.04
9-12 6 0 0 1.00 0.10 0.04
12-15 6 2 0 0.67 0.07 0.03
15-18 4 0 1 1.00 0.07 0.03
18-21 3 0 2 1.00 0.07 0.03
21-24 1 0 1 1.00 0.07 0.03
DISCUSSION
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Dr. Joseph L. Mills (Tucson, Ariz.). Dr. Idu, Dr. Buth,
and associates have just presented in detail the results of a
careful prospective duplex surveillance study of 300
patients who underwent infrainguinal vein bypass grafting.
This study was a multicenter trial that was performed at
three centers of excellence in The Netherlands and that
typifies the meticulous and thoughtful analysis of data for
which these authors are known. The following two objec-
tives were stated for the study: first, to assess the accuracy
of various duplex parameters to detect graft stenosis and,
second, to investigate whether graft revision without
angiography is justifiable.
With regard to the first objective, the authors evaluat-
ed 10 different parameters that included peak systolic
velocity at the site of the stenosis, velocity ratio, and ABI,
and they determined that velocity ratio was the most accu-
rate predictor of the prevalence of a greater than 70%
stenosis as determined by angiography. With both stan-
dard and rather complex statistical methods that included
ROC curves and the transient state methodology, the
authors determined that a velocity ratio of 3 had a better
correlation with a high-grade stenosis than a ratio of either
2.5 or 4. This conclusion leads to my first question.
Did the authors evaluate the sensitivity, specificity, and
accuracy of a velocity ratio of 3.5? This velocity ratio has
been determined and derived independently by multiple
North American investigators, including Dr. Joseph
Sladen in British Columbia and Strandness’s group in
Seattle. This ratio was confirmed recently in a prospective
study by our own group and published in January 1997.
We noted that for regression or stabilization of 20 lesions
in a series of 101 consecutive vein grafts, the mean veloc-
ity ratio for lesions that resolved completely was 3.2. This
ratio exceeds the threshold value recommended here by
the authors.
Anecdotally, over the last 5 years we have followed
over 300 grafts, and we have had only one graft with a
ratio that exceeded 3.5 in which the stenosis actually
resolved completely. I think that clinically useful threshold
criteria for repair are more accurately obtained from serial
observations of graft flow of abnormalities over time than
by any overreliance on angiography.
Now, the authors did report confirmation that grafts
with serial normal surveillance studies have an extremely
low failure rate. In addition, they recommend repair of all
graft lesions that have high-grade stenoses with ratios that
are greater than 4. Lastly, they suggested performing
angiography of all grafts with intermediate stenoses. I
maintain that the angiography of grafts of intermediate
lesions is unnecessary and will increase rather than
decrease the use of angiography. Intermediate lesions—
which we have defined as stenoses with peak systolic veloc-
ities that are less than 300 cm/sec and velocity ratios that
are between 2 and 3.4—should merely be subjected to
continued surveillance, albeit at increased frequency, per-
haps every 4 to 6 weeks. We have found that with this
method more than half of intermediate lesions stabilize or
regress completely, and this follow-up approach avoids
unnecessary angiography or repair. However, about 45%
of these lesions progress and require repair. With this
approach, we then have a minimal rate of spontaneous
graft thrombosis, and the period of resolution or progres-
sion usually occurs over a span of 4 to 5 months.
Finally, I would like to emphasize that to perform
duplex surveillance and base the decision for intervention
on high-velocity criteria such as the velocity ratio would be
unreasonable. Low-velocity criteria, such as a drop in ABI
or the development of a low graft flow state that is less than
45 cm/sec, may not be statistically significant but are high-
ly clinically significant when present. In this series, 84 grafts
ultimately required revision, and 12 of those grafts were
identified because the graft flow velocity or the ABI fell,
although no focal increased peak systolic ratio was within
the graft. Arteriography thus would be mandatory in such
cases to identify graft-threatening inflow or outflow lesions
and potential stenoses that could be missed by duplex.
I have three brief questions:
1. Did the authors evaluate the specificity, sensitivity, and
accuracy of the velocity ratio of 3.5?
2. Would the authors agree that low-velocity criteria,
which perhaps are not statistically significant, are very
useful clinically and that a velocity ratio by itself
should not be a sole criterion to dictate intervention?
3. Why subject intermediate grade lesions to angiogra-
phy? One of the main advantages of duplex ultrasound
is that the technique is noninvasive and permits serial
observations. Thus duplex ultrasound would avoid
both angiography and unnecessary operation by serial
observations of the intermediate lesions.
Finally, I would agree generally that preoperative
angiography is unnecessary in many lesions, particularly if
the lesions have been followed over a long period.
However, a graft should be assessed completely in the
operating room with angiography or duplex scanning,
because it is well known that duplex scanning has a weak-
ness of discovering the first stenosis in a series. Yet, for
example, when a high-grade proximal stenosis exists, a dis-
tal stenosis may be missed if the entire graft is not assessed.
I would like to thank the authors, and I recommend
the reading of their manuscript, which is complete and
meticulous. I would also like to thank the Society for the
privilege of discussion.
Dr. Jacob Buth. Dr. Mills, thank you for your com-
ments. We studied your previous work and your articles
extensively during the preparation of this study and man-
uscript.
You advised the use of duplex ultrasound studies with
increased frequency instead of arteriography in the group
that we defined as having the intermediate risk. That
method has pros and cons. Obviously, the number of
angiograms performed during follow-up can be reduced,
but is this reduction safe? In this study, 64 patients fell into
the intermediate category, and about 20 primary events
occurred, among which were five occlusions and 15 revi-
sions. These 15 revisions, if they had not been discovered
immediately by an angiogram, would have been subjected
to continued surveillance. The period for which the patients
were at risk would be prolonged, and they may have had
occlusion in the interval. These 15 patients, if they had all
had occlusion, would make up for a total decrease of the
secondary patency rate in the overall series by 5%.
Your first question asked whether we investigated the
sensitivity, specificity, and predictive values of other duplex
ratios, in particular a ratio of 3.5? Yes, we did, and a num-
ber of these transient-state curves were shown, but we
found that 3.0 was the most precise cutoff value, and we
stuck to it. We did not use the 3.5 threshold.
You mentioned that regression was a possibility and
would appear in a sizable proportion of the patients.
According to the literature—which included your own
studies—only a minority actually regress. The total num-
ber of patients who progress and remain stable is larger
than the number of patients who regress. We admit that
the regression lesions would benefit most from a protocol
of continued surveillance, but the progressive lesions are
the ones that cause worry.
We are safer performing an angiogram in the interme-
diate category, determining the precise angiographic
severity of the lesion, and, if the severity is less than 70%,
continuing surveillance from there. At this point we have
evidence that an angiographic reduction of 70% or greater
is the most solid criterion for a graft at risk for failure.
You have reconfirmed our observation that even in an
algorithm that uses the most optimal criterion of a PSV
ratio some additional criteria are useful, in particular the
low velocity criteria, the low-flow state of the graft, and
the return of severe symptoms that invariably are associat-
ed with a reduction of the interval ankle blood pressures.
I think we have shown that the decisions of when to inter-
vene or do an angiogram cannot be made completely on a
computerized algorithm.
I think that I have answered most of your questions.
Your recommendation of performing an intraoperative
angiogram or an intraoperative duplex scan during the
procedure is a good point that I think most people follow
as we do.
Dr. J. Dennis Baker (Los Angeles, Calif.) My question
addresses in part the topic you just mentioned. My con-
cern about operating on the basis of just the duplex scan
is that a percentage of these lesions are not focal stenoses
that are easily repaired but are stenoses that may have
either a focal stenosis with a long stricture distal to it or
just a long segment of stricture. In our experience we have
not been able to identify these long lesions very accurate-
ly, which is one of the reasons we have used angiography
at some point before the repair. Have you encountered
this type of lesion? We have seen this lesion in primarily in
situ–type reconstructions.
Dr. Buth. Dr. Baker, I agree that we have focused on
just one aspect, the severity of stenosis, but the other char-
acteristics of stenosis are important, too. For instance,
length determines the choice between treating a graft
stenosis by balloon angioplasty or by surgery, which makes
a lot of difference in your planning. However, we feel that
with the modern color-flow duplex equipment you usual-
ly are able to determine the length of the stenosis, multi-
plicity, and runoff lesions that coincide with the graft
stenosis.
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